Commentary on ACCP position statement on the use of microdosing in the drug development process.
Malcolm
M
Rowland
D035843:Biomedical Research / Q000379:methods*; D002986:Clinical Trials as Topic / Q000379:methods; D004305:Dose-Response Relationship, Drug; D006801:Humans; D004364:Pharmaceutical Preparations / Q000008:administration & dosage*; D010599:Pharmacokinetics; D010601:Pharmacology, Clinical; D012958:Societies, Scientific
D004364:Pharmaceutical Preparations